Business Trends

Oct 02, 2015
BioPharm International
Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies. JLL’s 2015 Life Sciences Outlook report highlights global clusters worth watching.
Oct 02, 2015
BioPharm International
This article examines trends in biopharma post-grant patent review and projects what the future holds in store.
Oct 02, 2015
BioPharm International
Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies. JLL’s 2015 Life Sciences Outlook report highlights global clusters worth watching.
Oct 01, 2015
BioPharm International
In the development of biopharmaceuticals and pharmaceuticals, the line is blurring.
Sep 01, 2015
BioPharm International
China’s emergence as a significant commercial market is forcing manufacturers to re-evaluate their overall business model.
Aug 07, 2015
European Union regulators said Pfizer must divest its infliximab biosimilar candidate and some sterile injectables for the merger with Hospira to be completely approved.
Aug 01, 2015
BioPharm International
FDA notes progress in drug development, but cites scientific and funding roadblocks.
Jul 10, 2015
The 21st Century Cures Act took a giant step forward with a 344-77 approval in the House; the Senate debate is still ahead.
Jul 01, 2015
BioPharm International Multimedia
By BioPharm International Editors
Eric Langer, Managing Partner at BioPlan Associates, speaks with BioPharm International about emerging trends in cell therapy.
Jul 01, 2015
BioPharm International Multimedia
By BioPharm International Editors
Jim Miller, President of PharmSource, speaks with BioPharm International.
native1_300x100
lorem ipsum